23 Biotech Startups in Zürich to Watch in 2024
How do we build this list?
Tracking:
Last update to the database: March 25, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Antibody discovery and human immune repertoire analysis platform. |
$27M · Series C | Vesalius Biocapital Partners, Adjuvant Capital, Swisscanto Private Equity | 11 to 50 | Health Tech, Biotech | B2B | Zürich, Switzerland | •••••••••••@memo-therapeutics.com | |
Generative AI platform for protein design and engineering. |
$24M · Series A | Index Ventures, Kindred Capital | 11 to 50 | AI, Biotech | B2B | Zürich, Switzerland | •••••••••••@cradle.bio | |
Gene therapy research to tackle genetic diseases. |
$59M · Series A | Gimv | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@anjarium.com | |
Self-adjuvanting and multi-antigen vaccine technology platform. |
$3M · Series A | Novo A/S, Adjuvant Capital, Repair Impact Fund | 11 to 50 | Health Tech, Biotech | Zürich, Switzerland | •••••••••••@lmtbio.com | ||
Developer of small molecules to treat novel drug resistance pathways in cancer therapy. |
$20M · Series A | BioMedPartners, Altos Ventures, Redalpine | 1 to 10 | Health Tech, Biotech | Zürich, Switzerland | •••••••••••@tolremo.com | ||
Glycanengineering platform. |
$49M · Series A | Sofinnova Partners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@glycoera.com | |
Immunotherapy platform for cancer. |
$330k · Pre Seed | Lightspeed Venture Partners, BioMedPartners, Gimv | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@immunostherapeutics.com | |
Microcaps develops a novel technology that enables the scalable production of precise microcapsules and microparticles. |
$5M · Seed | Helvetica Capital | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | Zürich, Switzerland | •••••••••••@microcaps.ch | |
BC Platforms is a data and technology company providing tools to advance the development of personalized medicine and precision medicine. |
$20M | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma, Data and Analytics, Business Intelligence | B2B, SaaS | Zürich, Switzerland | •••••••••••@bcplatforms.com | ||
Developer of an antibody-drug conjugates (ADCs). |
$110k · Pre Seed | btov Partners, Pureos Bioventures, Redalpine | 1 to 10 | Health Tech, Biotech | B2B | Zürich, Switzerland | •••••••••••@ararisbiotech.com | |
Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies. |
$25M · Series A | 1 to 10 | Health Tech, Fintech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@rejuveron.com | ||
Invasight is a clinical biotech company that focused on revolutionizing cell invasion research. |
$4M · Seed | High-Tech Gründerfonds, Verve Ventures | 1 to 10 | Health Tech, Biotech, Deep Tech | B2B | Zürich, Switzerland | •••••••••••@invasight.com | |
Virometix is a privately held biotechnology company developing |
$8M · Series B | 11 to 50 | Health Tech, Biotech | B2B | Zürich, Switzerland | •••••••••••@virometix.com | ||
Navignostics aims to identify the ideal treatment to each cancer patient’s disease. |
$7M | 1 to 10 | Health Tech, Hardware, Biotech, Deep Tech, Pharma | Zürich, Switzerland | •••••••••••@navignostics.com | |||
Medical robotics company. |
$12M · Series A | 11 to 50 | Biotech | Zürich, Switzerland | •••••••••••@nanoflexrobotics.com | |||
Rqmicro develops a pathogen separation and detection technology that delivers accurate results in less than 2 hours |
$6M · Series B | 11 to 50 | Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Business Intelligence | B2B | Zürich, Switzerland | •••••••••••@rqmicro.com | ||
Guided medical devices cardiovascular procedures. |
$4M · Series B | 1 to 10 | Biotech | Zürich, Switzerland | •••••••••••@medyria.com | |||
Groam provide bio-based and biodegradable foam solutions for fast disposables. |
$161k · Pre Seed | Venture Kick | Agritech, Biotech, Energy & Nuclear, Manufacturing | B2B | Zürich, Switzerland | •••••••••••@groamtech.com | ||
Biosimo Chemicals produces sustainable chemicals |
$308k · Pre Seed | 1 to 10 | Biotech, Deep Tech, Proptech & Real Estate, Manufacturing | B2B | Zürich, Switzerland | •••••••••••@biosimo-chemicals.com | ||
Vatorex enhances honey bee health through an effective and practicable hyperthermic system to fight the varroa mite. |
$1M | 1 to 10 | Climate Tech & Green Tech, Agritech, Hardware, Biotech | B2B | Zürich, Switzerland | •••••••••••@vatorex.ch | ||
Relief Therapeutics is a clinical stage biotechnology company. |
N/A | 11 to 50 | Biotech, Deep Tech | Zürich, Switzerland | •••••••••••@relieftherapeutics.com | |||
PharmaBiome is specialized in the isolation, characterization, and technology of novel intestinal microbes. |
N/A | 1 to 10 | Health Tech, Biotech, Deep Tech | Zürich, Switzerland | •••••••••••@pharmabiome.com | |||
Molecular Partners is a clinical-stage biopharmaceutical company. |
N/A | 51 to 100 | Biotech, Deep Tech | Zürich, Switzerland | •••••••••••@molecularpartners.com |
Sign up to access our full database
Enter your email and get access to 17,000+ technology companies you can partner with.